Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NEUPRO
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
- Dopaminergic Therapy for Frontotemporal Dementia Patients
- A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
- A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
- A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
- A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause
- Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management
- Non Motors Aspects in De Novo Parkinson's Disease
- Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
- Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch
- Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
- A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
- Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model
- Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease
- Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
- Switching From Oral Dopamine Agonists to Rotigotine
- Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
- Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects
- Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
- A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
- A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
- Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects
- Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects
- A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
- Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome
- Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
- Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support
- Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
- Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke
- A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery
- An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
- An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.
- Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
- Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
- An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease
- Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
- The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
- Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms
- Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease
Clinical trials list
click for details